"Clofibrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)
| Descriptor ID |
D002994
|
| MeSH Number(s) |
D02.241.081.114.968.500.500.195 D02.355.726.305.500.195 D02.455.426.559.389.657.654.305.500.195
|
| Concept/Terms |
Clofibrate- Clofibrate
- Ethyl Chlorophenoxyisobutyrate
- Chlorophenoxyisobutyrate, Ethyl
- Clofibric Acid, Ethyl Ester
|
Below are MeSH descriptors whose meaning is more general than "Clofibrate".
Below are MeSH descriptors whose meaning is more specific than "Clofibrate".
This graph shows the total number of publications written about "Clofibrate" by people in this website by year, and whether "Clofibrate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clofibrate" by people in Profiles.
-
Clofibrate induces heme oxygenase 1 expression through a PPARa-independent mechanism in human cancer cells. Cell Physiol Biochem. 2013; 32(5):1255-64.
-
Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling. Mol Pharmacol. 2009 Sep; 76(3):588-95.